- 1 -

EMPLOYMENT AGREEMENT

THIS AGREEMENT made the 29st day of June, 2017.

BETWEEN:

ONCOLYTICS BIOTECH (U.S.), INC.

("OBUS")

-and-

ANDREW DE GUTTADAURO

(the "Employee")

WHEREAS:

A. OBUS and its Affiliates are engaged in the business of developing pharmaceutical products;

B. OBUS has made an offer of employment to the Employee, subject to the terms and conditions contained herein, and subject to the termination of the Services Agreement concurrent with the commencement of employment under this Agreement;

C. The Employee is prepared to accept the offer of employment;

NOW THEREFORE the parties agree as follows:

Section 1 - Definitions and Interpretation

(1)In this Agreement the following defined terms shall have the meanings indicated:

(a) ”Affiliate” means any entity that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with a party. For the purposes of this definition, control shall mean: (i) the direct or indirect ownership of fifty percent (50%) or more of the voting stock of a corporation; or (ii) the direct or indirect ownership of fifty (50%) or more of the ownership interest of any other entity; or (iii) the ability to elect a majority of the directors of the entity;

(b) "Business" means the business currently carried on by OBUS and its Affiliates, which is the development, testing, marketing and sale of pharmaceutical products together with such additional business as OBUS or its Affiliates may decide to undertake from time to time;

(c) "Commencement Date" means July 3, 2017;

(d) “Good Reason” means any one of the following events occurring on or after the Commencement Date:

(i) Any reduction in the Employee’s then existing annual base compensation and benefits, unless comparable reductions are made for all other executive employees of Oncolytics;

(ii) Any material diminution of the Employee’s duties, responsibilities, authority or reporting structure, excluding for this purpose an isolated or inadvertent action

- 2 -

not taken in bad faith which is remedied by Oncolytics immediately after notice thereof is given by the Employee;

(iii) Any request that the Employee relocate to a work site that would increase the Employee’s one-way commute distance by more than eighty (80) kilometers from the Employee’s then principal residence, unless the Employee accepts such relocation opportunity; or

(iv) Any material breach by Oncolytics of its obligations under this agreement that is not remedied within thirty (30) days of written notice of such breach from the Employee;

(e) "Confidential Information" means all confidential information of OBUS and its Affiliates, and includes:

(i) any data or information directly or indirectly related to the Business or arising directly or indirectly in the course of, or derived from the Employee's employment with OBUS whether related to products, equipment, inventions, ideas, designs, methods, systems, improvements, processes, research or otherwise;

(ii) any technical or scientific know-how;

(iii) financial and sales information, customer lists, pricing policies, lists of suppliers, proprietary computer programs in any format whatsoever, programming techniques, the manner of plans or methods of operation and the like relating to the Business;

(iv) patent applications, drawings, blueprints, manuals, letters, notebooks, reports and all other materials (written or otherwise) related to the Business or to the agents, joint venturers or contractors of OBUS or its Affiliates; and

(v) any information provided to or received by OBUS or its Affiliates on a confidential basis;

(f) "Intellectual Property" means all information, data, designs, processes, software, algorithms and inventions, including those that may be the subject of patent, copyright, industrial design, trademarks, trade secret or other forms of legal protection, made, conceived or developed by the Employee during the term of employment with OBUS, whether alone or jointly with others and whether during or after regular working hours, that relates to or in any way pertains to or connects with any matter developed, or under investigation or development by OBUS or its Affiliates, or related to the Business;

(g) "Cause" means:

(i) breach by the Employee of any material provision of this Agreement;

(ii) material violation by the Employee of any statutory or common law duty of loyalty to OBUS and its Affiliates;

(iii) Employee’s failure to perform Employee’s duties for the Company in a competent and effective manner as judged in good faith by either the Chief

- 3 -

Executive Officer of the Company or the Company’s Board of Directors in their sole discretion.

(iv) the commission of a criminal offence by the Employee against OBUS or its Affiliates; or

(v) personal or professional conduct of the Employee which in the reasonable and good faith judgment of OBUS may significantly injure OBUS' Business or interfere with the Employee's job performance.

(2)This Agreement shall be governed by and construed in accordance with the laws of California.

(3)The parties shall with reasonable diligence take all action, do all things, attend or cause their representatives to attend all meetings and execute all further documents, agreements and assurances as may be required from time to time in order to carry out the terms and conditions of this Agreement in accordance with their true intent.

(4)The following schedules are attached to and form part of this Agreement:

Schedule "A" – Job Description

Schedule "B" – Benefits

Section 2 -Employment

(1)OBUS agrees to employ the Employee in the position of Vice President, Business Development and the Employee accepts the employment, starting on the Commencement Date.

(2)The Employee shall perform the duties and responsibilities associated with the position of Vice President, Business Development including those set out on the Job Description attached as Schedule "A". The Employee may, from time to time, be assigned or undertake additional duties and responsibilities consistent with those generally appropriate for a Vice President, Business Development and the Employee's duties and responsibilities may be modified or expanded from time to time.

(3)The Employee shall perform the duties and responsibilities set out in Section 2(2):

(a) diligently, faithfully and to the best of the Employee's ability; and

(b) in the best interests of OBUS.

(4)The Employee shall comply with the terms, conditions and requirements of OBUS' Policy Manual and benefit plans, as the same may be amended, revised or added to from time to time.

- 4 -

Section 3 -Remuneration

(1)OBUS shall pay to the Employee a salary of Two Hundred and Thirty Thousand ($230,000.00) United States dollars per annum, exclusive of bonuses, benefits and other compensation, payable in equal installments of Nine Thousand Five Hundred and Eighty-Three United States Dollars and Thirty-Three Cents ($9,583.33) on the fifteenth (15) and last day of each month.

(2)OBUS shall, on or before the anniversary date of this Agreement in each year, evaluate and set the Employee's salary for the next ensuing year.

(3)OBUS shall reimburse the Employee for all reasonable out-of-pocket expenses incurred by the Employee in the performance of the Employee's obligations under this Agreement, subject to OBUS' policies then in force.

(4)OBUS shall be entitled to withhold from any payments made to the Employee any amounts that OBUS is required to withhold pursuant to any Act in force that relates to income tax, social security, medicare or pension in any jurisdiction under which such payments are required to be made by or on behalf of the Employee.

Section 4 -Benefits and Equity Compensation

The Employee shall be entitled to participate in benefit plans described in Schedule "B" and in other benefit plans instituted or as amended by OBUS from time to time.

Performance Share Units

The Employee shall be granted 60,000 restricted share units (“RSU’s”) on the Commencement Date under Oncolytic Biotech Inc.’s Incentive Award Plan. One third of the RSU’s will vest after the second employment anniversary with the remaining two thirds of the RSUs vesting after three years of service.

Stock Options

The Employee shall be granted 125,000 stock options on the Commencement Date under Oncolytics Biotech Inc.’s Stock Option Plan. These options will be priced on the Commencement Date and 25% of the stock options will vest immediately, followed by 25% vesting after twelve (12) months from the Commencement Date and the final 50%vesting after twenty-four (24) months from the Commencement Date.

Section 5 -Vacations

The Employee shall, in addition to all statutory holidays, be entitled to twenty (20) Business Days paid vacation during each twelve (12) month period of employment under this Agreement. The Employee's vacation time shall be governed by applicable policies of OBUS.

- 5 -

Section 6 -Place of Employment

The Employee shall perform the majority of the Employee’s employment obligations from and out of the Company’s offices located in La Jolla, California.

The Employee shall be available to travel within the United States and outside the United States as required to fulfill his duties and responsibilities.

Section 7 -Confidential Information

(1)The Employee confirms that the Confidential Information is the sole and exclusive property of OBUS or its Affiliates and is held by the Employee in trust for the benefit of OBUS and its Affiliates. The Employee shall use the Employee's best efforts and exercise utmost diligence to protect and safeguard the Confidential Information. Neither during the period of employment by OBUS nor thereafter for a period of three years shall the Employee, directly or indirectly, use or disclose to any other person any Confidential Information, whether or not acquired, learned or obtained or developed by the Employee alone or in conjunction with others, except as such disclosure or use may be required in connection with the employment with OBUS or as may be agreed to in writing by OBUS.

(2)Subsection 7(1) shall not apply to Confidential Information that:

(a) is in the public domain at the time of its disclosure, or which, after disclosure, becomes part of the public domain other than by disclosure by the Employee;

(b) the Employee can show was in the Employee's possession at the time of disclosure and was not acquired from OBUS or its Affiliates; or

(c) was received by the Employee from a third party without a covenant of confidentiality, provided such third party is under no obligation of confidentiality with respect to the Confidential Information.

(3)The Employee shall keep informed of OBUS' policies and procedures for safeguarding OBUS' property including, without limitation, the Confidential Information and the confidentiality thereof, and will strictly comply therewith at all times. The Employee shall not, except as required in the course of the employment with OBUS, remove from OBUS' premises any OBUS property including, without limitation, Confidential Information. The Employee shall, immediately upon termination of employment with OBUS, return to OBUS all of OBUS' property in the Employee's possession, including, without limitation, all tangible parts of or relating to the Confidential Information as is in the Employee's possession or under the Employee's control without retaining any copies or record thereof or any other mechanical means that, alone or in combination with other means, would permit the Employee to reproduce or make available the Confidential Information.

(4)The Employee shall advise any future employer, associate or affiliate that the Employee has signed this Agreement and is bound by its terms and conditions.

Section 8 -Intellectual Property

(1)The Employee confirms that any and all Intellectual Property shall be the sole and exclusive property of OBUS or its Affiliates and shall be assigned by the Employee to OBUS, or its nominee. The Employee agrees to disclose promptly to OBUS or its nominee any and all Intellectual Property and to

- 6 -

execute written assignments of the Employee's right, title and interest in and to the Intellectual Property to OBUS or its nominee.

(2)With respect to any Intellectual Property, the Employee also agrees:

(a) to assist OBUS or its nominee in preparing any necessary copyright and patent applications, including Canadian and foreign applications, covering the Intellectual Property;

(b) to sign and deliver all such applications and their assignment to OBUS or its nominee; and

(c) generally to give all information and testimony, to co-operate with OBUS and its solicitors, to sign all lawful papers, and to do all lawful things that may be needed or requested by OBUS to obtain, extend, reissue, maintain or enforce copyrights or patents covering the Intellectual Property.

(3)OBUS shall bear all expenses that are incurred in obtaining, extending, reissuing, maintaining and enforcing any and all copyrights or patents in respect of the Intellectual Property assigned to OBUS or its nominee by the Employee, and in the vesting and perfecting of title thereto in OBUS or its nominee and shall pay the Employee reasonable compensation for any time that OBUS may require the Employee to expend in order to accomplish the above subsequent to the termination of employment with OBUS.

(4)The Employee hereby waives in favour of OBUS and its Affiliates, all moral rights in any and all copyright works authored or co-authored by the Employee during the term of this Agreement that directly relate to the Business of OBUS or its Affiliates.

(5)In accordance with California Labor Code Section 2870, Employee is notified that:

(a) Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret information except for those inventions that either:

(b) Relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or

(c) Result from any work performed by the employee for the employer.”

- 7 -

Section 9 -Term and Termination

(1)The Employee's employment under this Agreement shall commence on the Commencement Date and shall continue until terminated in accordance with this Section 9.

(2)If OBUS has Cause to terminate Employee’s employment as “Cause” is defined above, OBUS shall not be required to compensate the Employee in respect of such termination or provide any period of notice in lieu of compensation with respect to such termination.

(3)Subject to Section 9(4), if this Agreement is terminated by OBUS for any reason other than for Cause, or if this Agreement is terminated by the Employee for Good Reason, the Employee shall be entitled to severance in the form of continued salary for six (6) months after the termination of Employee’s employment (the “Severance Period”) at the rate in effect on the date of Employee’s termination. Within 14 days of the end of the Severance Period, Employee shall also be entitled to a payment in an amount equal to the value of all benefits to which the Employee would otherwise have been entitled during the Severance Period.

(4)Notwithstanding Section 9(3), if there is a change of control of OBUS, as defined herein, and if this Agreement is terminated by OBUS at any time within one (1) year following the change of control other than for Cause, the Employee shall be entitled to twenty-four (24) months of continued salary at the rate in effect on the date of Employee’s termination. Within 14 days of the end of the twenty-four (24) months of continued salary, Employee shall also be entitled to a payment in an amount equal to the value of all benefits to which the Employee would otherwise have been entitled during the twelve (12) month continued salary period.

For the purposes of this section 9(4), “change of control” means any amalgamation, merger or other corporation reorganization which results in any change in the present effective voting control of OBUS, or will result in a change of the person or persons who own or control sufficient voting shares in OBUS to elect a majority of the directors of OBUS, or will result in a person acquiring sufficient voting shares in OBUS to elect a majority of the directors of OBUS, or any sale, lease, exchange, partnership, or other transfer (in one transaction or a series of transactions) of all or substantially all of the assets of OBUS or a plan of liquidation of OBUS and/or an agreement for the sale or liquidation of OBUS is approved and completed, or the Board of Directors determines in its sole discretion the a change of control has occurred, whether or not any event described has occurred or is contemplated.

(5)The Employee confirms that:

(a) any breach of this Agreement or unauthorized disclosure of Confidential Information may result in irreparable harm to the Business of OBUS or its Affiliates and considerable monetary damages to OBUS and its Affiliates;

(b) the damages suffered by OBUS may be difficult to establish; and

(c) interim and permanent injunctions may be the only suitable remedy for OBUS;

but nothing herein shall in any way limit or restrict any other remedies available to OBUS at law or in equity including an action for damages.

- 8 -

(6)Termination of the Employee's employment with OBUS for any reason whatsoever shall not terminate the Employee's obligations under Sections 7, 8 and 10 of this Agreement.

Section 10 -Non-Competition

(1)The Employee shall not, during the term of this Agreement, engage, hold an interest in or have any involvement, either directly or indirectly, in any business entity, venture or undertaking if such would materially interfere with or conflict with the Employee's duties and obligations to OBUS as provided for under this Agreement, provided that the acquisition of a non-control position in publicly traded companies will not contravene this Section.

(2)The Employee shall not, during the term of this Agreement, either individually or in partnership or jointly or in conjunction with any person, firm or corporation as principal, employee, partner, director or as a shareholder or investor (if actually involved in the management of a business which is competitive with the Business of OBUS or its Affiliates) carry on or be engaged in any business which is directly competitive with the Business of OBUS or its Affiliates.

Section 11 -Notices

All notices, reports, invoices, payments and formal communications (collectively referred to as "Notices") required or permitted to be given hereunder shall be in writing and shall be delivered personally or sent by prepaid registered mail or facsimile transmission to the following address or such other address as the relevant party may notify from time to time:

TO:    OBUS

ONCOLYTICS BIOTECH (U.S.), INC.

Attention: President

WITH COPY TO:

ONCOLYTICS BIOTECH INC.

Suite 210, 1167 Kensington Crescent N.W.

Calgary, Alberta

T2N 1X7

Attention: President

TO:    Employee

Andrew de Guttadauro

Notices sent by prepaid registered mail shall be deemed to be received by the addressee on the seventh day (excluding Saturdays, Sundays, Statutory Holidays and any period of postal disruption) following the mailing thereof. Notices personally served shall be deemed to be received when actually delivered, provided such delivery shall be during normal business hours.

Section 12 -Enurement

- 9 -

This Agreement shall enure to the benefit of and be binding upon the parties hereto and:

(a) in the case of OBUS, its successors and permitted assigns; and

(b) in the case of the Employee, his heirs, executors, administrators or other personal representatives.

IN WITNESS WHEREOF the parties have executed this Agreement as of the day and year first above written.

ONCOLYTICS BIOTECH (U.S.), INC.
Per:	/S/ Andres Gutierrez
	Andres Gutierrez Director
Per:	/S/ Gilles Gosselin
	Gilles Gosselin Director

/s/ Roshawn Blunt/S/ Andrew de Guttadauro        

Witness                Andrew de Guttadauro

SCHEDULE "A"

JOB DESCRIPTION

INSERT JOB DESCRIPTION

SCHEDULE "B"

BENEFITS

Physical Fitness Benefit:

The Employee is entitled to the Physical Fitness Benefit in the amount of Seven Hundred and Fifty ($750.00) United States Dollars per annum to use towards an item or service that promotes physical activity; the details of which are outlined in the Company Policy Manual.

Deferred Compensation:

Employee shall, if qualified to do so, be entitled to allocate a portion of his salary to a 401(K) Plan established for the Employee, up to the prescribed maximum, and in accordance with the requirements thereof.

Benefit Plan Alternatives:

Alternative 1:

Employee can elect to receive an additional amount of 9.25% of base salary. Such amount shall be the employee’s full Health Benefit Allocation, and shall be taxable in accordance with the relevant regulations.

Alternative 2:

Employee can elect to direct (the lesser of the maximum available or allowable by the employee under the Flexible Spending Plan), a portion of the Health Benefit Allocation (9.25% of base salary) to a Flexible Spending Account, and receive the remainder (9.25% of base salary less the amount directed to the Flexible Spending Account) of the Health Benefit Allocation as a taxable amount in accordance with the relevant regulations.

Alternative 3:

Whether or not the Employee elects to participate in Alternative 2, the Employee can also elect to participate in an individual Health Insurance Program utilizing any amount still remaining from the Health Benefit Allocation. Any additional amounts required to be paid for this Program would be drawn from Employee’s net pay.